Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
270 participants
INTERVENTIONAL
2009-11-24
2013-10-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: To evaluate the efficacy of a social worker to prevent behavioural problem for patient with a new diagnosis of Alzheimer disease or associated disorder.
Design and setting: Multicentric cluster randomized control trial. Patients from several memory consultations and specialists (neurologist, psychiatrist or geriatrician) in France are included.
Intervention: In addition to usual care, patients in the intervention group have systematic home visits from a social worker and regular follow-ups by phone over a one-year period. This social worker informs the patient and caregiver, evaluates the needs, gives advices to prevent complications and is a link between the patient and the memory consultation or the specialist. Patient in the control group have absolutely no intervention and are followed-up as usually. In order to not modify the usual care, they have no information on their participation in this trial before the one-year evaluation.
Main outcome measure: NeuroPsychiatric Inventory (NPI) administrated at one year, which evaluates frequency, severity and repercussion of several behavioural problems. Secondary outcomes included disability, cognition, depression, health, quality of life, institutionalization, and resource use.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pharmaceutical Collaborative Care Integrated to a Multidisciplinary Psychosocial Program
NCT02802371
Comparison for the Patient With Alzheimer Disease the Impact of Three Different Groups of Patient Care
NCT01639586
Impact of Therapeutic Educational Programme on the Alzheimer's Disease Affected Patient's Quality of Life
NCT01796314
Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease
NCT01819714
Maintenance of Occupational Therapy for Patients With Alzheimer
NCT03435705
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Social worker
Intervention of the social worker
Systematic home visits and regular follow-ups by phone from a social worker
Control
Control group is followed-up as usually (usual care)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention of the social worker
Systematic home visits and regular follow-ups by phone from a social worker
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of an informal caregiver
* Mild to moderately severe dementia (MMSE \[10-28\])
* Diagnosis of dementia made by a specialist ≤ 6 months
* Patient affiliated to the national health insurance system
Exclusion Criteria
* Patient on legal guardianship
* Behavioural problem with important clinical repercussion
* Psychotic syndrome
* Severe and unstable general pathology
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut de Sante Publique, d'Epidemiologie et de Developpement
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ISPED (Institut de Santé Publique, d'Epidémiologie et de Développement)
Bordeaux, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RCB : 2009-A00326-51
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.